Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Dec;262(12):2676-7.
doi: 10.1007/s00415-015-7897-y. Epub 2015 Sep 26.

Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome

Affiliations
Case Reports

Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome

D P Kidd. J Neurol. 2015 Dec.

Abstract

The objective of this study is to describe a case of severe and treatment-resistant neurological Behçet's syndrome responsive to a novel therapy. This case report describes the patient who failed to respond to conventional therapy but the brain stem lesion resolved with the anti-CD20 biological agent rituximab. Neurological complications are uncommon in Behçet's syndrome; 80% involve a meningoencephalitis which can be severe and relapsing. This is the first report of effectiveness of rituximab in this uncommon disease.

Keywords: Behçet’s syndrome; Neurological; Rituximab; Treatment.

PubMed Disclaimer

References

    1. Arthritis Rheum. 2008 Feb 15;59(2):285-90 - PubMed
    1. Mod Rheumatol. 2008;18(3):306-8 - PubMed
    1. Semin Arthritis Rheum. 2011 Aug;41(1):61-70 - PubMed
    1. Lancet Neurol. 2009 Feb;8(2):192-204 - PubMed
    1. Mediators Inflamm. 2014;2014:107421 - PubMed

Publication types

LinkOut - more resources